Lpath Names Dr. Dario Paggiarino Chief Development Officer, Senior Vice President

Lpath, San Diego-based therapeutic antibody company, has announced the appointment of Dario Paggiarino, MD, as its senior vice president and chief development officer, according to a report by The Wall Street Journal.

Advertisement
Carrie Pallardy

Dr. Paggiarino has previously held several executive positions in the area of ophthalmology for companies including Alcon, Pfizer Global R&D and Pharmacia Global.

Lpath is currently developing drugs for wet macular degeneration and renal cell carcinoma patients.

More Articles on Ophthalmology:
3 Statistics on Cataract Surgery Procedure Times in ASCs
New York Medical Society Names Dr. Sam Unterricht President
Study Finds Optomap Increases Retinal Lesion Detection

How the University of South Florida’s EP cardiac clinic drove 67% patient growth + doubled cardiac monitoring revenue

Recommended Whitepaper

Advertisement

Next Up in Ophthalmology

  • Montana physician practice acquired 

    Southlake, Texas-based Retina Consultants of America has acquired Montana Retina Consultants, according to a Feb. 5 news release.  Bozeman-based Montana…

    By: Patsy Newitt

  • Louisiana ophthalmology practice acquired 

    Vision Innovation Partners acquired Ophthalmic Associates of Alexandria (Va.), according to a Feb. 2 press release. Founded in 2010, Ophthalmic…

    By: Patsy Newitt

  • American Board of Ophthalmology names CEO

    The American Board of Ophthalmology has appointed Steven Gedde, MD, as its next CEO.  Dr. Gedde is an ophthalmologist and…

    By: Cameron Cortigiano
Advertisement

Comments are closed.